SCHEMBL4618472

SCHEMBL4618472

COC(=O)CNC(=S)N1CCC(NS(=O)(=O)c2cc(S(=O)(=O)c3ccc(F)cc3)ccc2C(C)C)CC1

nearest known ligand 0.47

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 15/20 0.47
WNT3 P56703 6/20 0.47
HTR1A P08908 5/20 0.42
HTR7 P34969 5/20 0.42
DRD2 P14416 2/20 0.42
HTR6 P50406 2/20 0.42
HTR2A P28223 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4615830 0.92 SFRP1 (0.48) SFRP1WNT3
SCHEMBL4618397 0.86 SFRP1 (0.42) SFRP1WNT3HTR1AHTR7DRD2
SCHEMBL4616576 0.85 SFRP1 (0.47) SFRP1WNT3
SCHEMBL4618100 0.84 SFRP1 (0.51) SFRP1WNT3HTR1AHTR7DRD2
SCHEMBL4618006 0.83 SFRP1 (0.49) SFRP1WNT3HTR1AHTR7DRD2
SCHEMBL6102396 0.83 SFRP1 (0.51) SFRP1WNT3
SCHEMBL4618682 0.83 KMT2A (0.48) SFRP1WNT3
SCHEMBL4617167 0.83 KMT2A (0.54)
SCHEMBL4616324 0.83 SFRP1 (0.60) SFRP1WNT3
SCHEMBL4731783 0.83 TSHR (0.52) SFRP1WNT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885WNT3 346/4885HTR1A 3561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.